Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

作者: J Durant , P Clevenbergh , P Halfon , P Delgiudice , S Porsin

DOI: 10.1016/S0140-6736(98)12291-2

关键词:

摘要: … Drug resistance is the inevitable consequence … genetic variability have led to the production of many HIV-1 variants with decreased drug susceptibility.1, 2 There are currently ten drugs …

参考文章(12)
Charles C. J. Carpenter, Margaret A. Fischl, Scott M. Hammer, Martin S. Hirsch, Donna M. Jacobsen, David A. Katzenstein, Julio S. G. Montaner, Douglas D. Richman, Michael S. Saag, Robert T. Schooley, Melanie A. Thompson, Stefano Vella, Patrick G. Yeni, Paul A. Volberding, Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel JAMA. ,vol. 280, pp. 78- 86 ,(1998) , 10.1001/JAMA.280.1.78
Graeme J. Moyle, Brian G. Gazzard, David A. Cooper, Jos?? Gatell, Antiretroviral therapy for HIV infection. A knowledge-based approach to drug selection and use. Drugs. ,vol. 55, pp. 383- 404 ,(1998) , 10.2165/00003495-199855030-00005
Charles C. J. Carpenter, Antiretroviral Therapy for HIV Infection in 1997 JAMA. ,vol. 277, pp. 1962- 1969 ,(1997) , 10.1001/JAMA.1997.03540480062040
Steven G. Deeks, Frederick M. Hecht, Melinda Swanson, Tarek Elbeik, Richard Loftus, P. T. Cohen, Robert M. Grant, HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS. ,vol. 13, ,(1999) , 10.1097/00002030-199904160-00001
Daniel Kaufmann, Giuseppe Pantaleo, Philippe Sudre, Amalio Telenti, CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART) The Lancet. ,vol. 351, pp. 723- 724 ,(1998) , 10.1016/S0140-6736(98)24010-4
Gerd Fätkenheuer, Albert Theisen, Jürgen Rockstroh, Tanja Grabow, Christian Wicke, Katja Becker, Ulrike Wieland, Herbert Pfister, Marcel Reiser, Petra Hegener, Caspar Franzen, Achim Schwenk, Bernd Salzberger, Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS. ,vol. 11, pp. 1402- 1403 ,(1997) , 10.1097/00002030-199714000-00001
David D. Ho, Avidan U. Neumann, Alan S. Perelson, Wen Chen, John M. Leonard, Martin Markowitz, Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature. ,vol. 373, pp. 123- 126 ,(1995) , 10.1038/373123A0
Luc Perrin, Amalio Telenti, HIV Treatment Failure: Testing for HIV Resistance in Clinical Practice Science. ,vol. 280, pp. 1871- 1873 ,(1998) , 10.1126/SCIENCE.280.5371.1871
Robert W Shafer, Mark A Winters, Sarah Palmer, Thomas C Merigan, Multiple Concurrent Reverse Transcriptase and Protease Mutations and Multidrug Resistance of HIV-1 Isolates from Heavily Treated Patients Annals of Internal Medicine. ,vol. 128, pp. 906- 911 ,(1998) , 10.7326/0003-4819-128-11-199806010-00008
C. C. Carpenter, Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA JAMA: The Journal of the American Medical Association. ,vol. 276, pp. 146- 154 ,(1996) , 10.1001/JAMA.276.2.146